Zacks: Analysts Expect Vaxxinity, Inc. (NASDAQ:VAXX) to Anno

Brokerages predict that Vaxxinity, Inc. (NASDAQ:VAXX – Get Rating) will announce earnings of ($0.34) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Vaxxinity’s earnings, with the lowest EPS estimate coming in at ($0.36) and the highest estimate coming in at ($0.32). The company is expected to issue […]

Related Keywords

United States , , Geode Capital Management , Virtu Financial , Zacks Investment Research , Investment Advisers , Vaxxinity Company Profile Get Rating , Managers Group , Nasdaq , Vaxxinity Inc , Millennium Management , Get Rating , Capital Management , Company Profile , Lewy Body , Vaxxinity , Nasdaq Vaxx , Vaxx , Medical , Ratings , Consensus ,